177 results
8-K
EX-3.1
9l6 x6r6pkx9ybikxwaz
17 Nov 22
Material Modifications to Rights of Security Holders
5:20pm
DEFA14A
1njp1s0
30 Sep 22
Additional proxy soliciting materials
4:18pm
8-K
EX-10.5
sm6 bfsg2r4y
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-2.1
nasjg4
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.4
i9kq7tz
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
DEFA14A
EX-99.1
fep2o6s
28 Sep 22
Additional proxy soliciting materials
4:59pm
8-K
EX-99.1
ql5q8x
28 Sep 22
Idera Pharmaceuticals Acquires Aceragen
4:29pm
8-K
EX-99.1
cljt74s8t8n7mppuq2z
17 May 22
Idera Pharmaceuticals Shares Positive Results from Investigator- Sponsored Trial in Melanoma Patients at Amsterdam UMC
10:14am